Plaintiffs’ lawyers have requested a new multidistrict litigation for lawsuits alleging that Sanofi SA’s chemotherapy drug Taxotere can cause permanent hair loss in women, particularly those being treated for breast cancer.
In a July 22 motion, lawyers for two plaintiffs asked the U.S. Judicial Panel on Multidistrict Litigation to send Taxotere litigation - currently comprising 33 lawsuits in 16 federal courts - to the U.S. District Court for the Eastern District of Louisiana.
To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2aJJDCH
